Flamée, P., de Asmundis, C., Bhutia, J.T., Conte, G., Beckers, S., Umbrain, V., et al. (2013) Safe Single-Dose Administration of Propofol in Patients with Established Brugada Syndrome: A Retrospective Database Analysis. Pacing and Clinical Electrophysiology, 36, 1516-1521.
https://doi.org/10.1111/pace.12246

has been cited by the following article:

• TITLE: Brugada Syndrome: Anesthesia Management

  AUTHORS: Ezgi Erkiliç, Ayça T. D. Özcan, Tülin Gümüş, Yüce İslamoğlu, Betül Akaycan, Orhan Kanbak

  KEYWORDS: Brugada Syndrome (BrS), Cardiac Arrhythmia, Ventricular Fibrillation, Anesthesia

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.9 No.9, September 23, 2021

  ABSTRACT: Brugada’s Syndrome (BrS) is a rare but highly risky medical condition. It is a genetic disorder that may result in Ventricular Fibrillations (VF) that can lead to sudden cardiac arrest. The highest possible standards of safety in anesthetic medications must be followed and adequate measures must be taken with sufficient monitorization in patients with BrS. We wanted to mention the importance of monitorization in the early detection of possible complications and a careful follow-up even though no administration of anesthetic medication is present.